For rheumatoid arthritis, doses of 20 mg or more per week are generally considered high. The FDA-approved labeling specifically notes that doses above 20 mg weekly carry an increased risk of serious side effects, including bone marrow suppression. Most rheumatologists work within a range of 7.5 to 25 mg per week, with some patients going up to 30 mg depending on their response and tolerance.
How RA Dosing Compares to Other Uses
It’s worth understanding that “high dose” means something very different in RA than it does in cancer treatment. In oncology, high-dose methotrexate refers to 500 mg per square meter of body surface area or more, often given intravenously. That’s hundreds of times larger than what’s used for RA. When rheumatologists talk about a high dose, they mean the upper end of a much narrower range: roughly 20 to 30 mg taken once a week.
The recommended starting dose for RA is 7.5 mg orally once per week. From there, your doctor will typically increase the dose in steps. The 2021 American College of Rheumatology guidelines conditionally recommend reaching at least 15 mg per week within four to six weeks, since doses below that threshold often aren’t enough to control the disease. Beyond 15 mg, further increases can provide additional benefit, but the tradeoff between effectiveness and side effects becomes more relevant.
The Typical Escalation Path
A systematic review published in the Annals of the Rheumatic Diseases found that the optimal strategy is to start at 15 mg per week orally, then increase by 5 mg each month until reaching 25 to 30 mg per week or the highest dose you can tolerate. Starting directly at 25 mg per week did produce greater clinical improvement, but it also caused more gastrointestinal side effects. The gradual approach balances effectiveness with tolerability.
Most people who respond to methotrexate notice improvement within three to six weeks, though it can take up to 12 weeks. If you’re not seeing results at a lower dose, your doctor will likely push the dose higher before considering a switch to other medications. The goal is to find the dose that controls your inflammation without causing unacceptable side effects.
Why Your Doctor May Switch to Injections
Once you’re above 15 mg per week, how you take methotrexate matters nearly as much as the dose itself. Oral methotrexate has a bioavailability problem at higher doses: your gut can only absorb so much at once, and absorption plateaus around 15 mg. Subcutaneous (self-injected) methotrexate doesn’t have this ceiling. It delivers a linear, dose-proportional increase in the amount of drug that actually reaches your bloodstream.
The difference is substantial. At 30 mg, the bioavailability of an oral dose is only about 64% of what a subcutaneous injection delivers. Even at 15 mg, injections provide roughly 49% more drug exposure than the equivalent oral dose. This means that if you’re taking 20 or 25 mg orally and not getting adequate control, switching to injections at the same dose can feel like a meaningful bump in effectiveness, sometimes without needing to increase the milligrams at all. Injections also tend to cause fewer stomach-related side effects, since the drug bypasses the digestive system entirely.
Side Effects at Higher Doses
Gastrointestinal toxicity is the main dose-limiting problem with methotrexate. Nausea, mouth sores, and stomach discomfort become more common as the dose climbs. These are the side effects that most often prevent people from reaching or staying at higher doses.
Beyond GI symptoms, doses above 20 mg per week increase the risk of myelosuppression, which means your bone marrow produces fewer blood cells. This can show up as unusual fatigue, easy bruising, or increased susceptibility to infections. Liver enzyme elevations are also more common at higher doses. Your doctor will order regular blood tests to monitor your liver function and blood counts, and these checks become especially important once you’re in the higher dose range.
Folic acid supplementation is standard for anyone on methotrexate for RA, and it becomes even more important at higher doses. Methotrexate works in part by interfering with how your body uses folate, and supplementing with folic acid helps reduce side effects like nausea, mouth sores, and abnormal liver tests without reducing the drug’s effectiveness against your arthritis.
When a High Dose Isn’t Enough
If you’ve been titrated up to 25 mg per week (or the highest dose you can tolerate), tried subcutaneous injections, and your RA still isn’t well controlled after three months or so, your rheumatologist will likely discuss adding or switching to other medications. This often means adding a biologic or targeted therapy. The ACR guidelines treat methotrexate as the foundation of RA treatment, and reaching an adequate dose is considered an important step before concluding it isn’t working for you. Being on 10 mg and not improving isn’t the same as being on 25 mg and not improving; the latter is a much stronger signal that you need a different approach.